RSS   Newsletter   Contact   Advertise with us
Post Online Media

Forma Therapeutics appoints Karoline Shair as vice president

Forma TherapeuticsForma Therapeutics, an integrated research and development company, announced the appointment of Karoline Shair as VP, legal and chief intellectual property counsel.
Article continues below

READ MORE STX Europe: Karoline Vinsrygg resigns, Hans-Jorgen Wibstad new chief of strategy

Ms. Shair joins the FORMA leadership team with over 20 years’ global experience in the biotechnology and pharmaceutical sector.

Ms. Shair most recently served as Vice President and IP Region Head, at Takeda Pharmaceuticals International Co., in Cambridge, Massachusetts.

She gained relevant bench experience designing novel drug candidates at Sloan Kettering Institute for Cancer Research and Ariad Pharmaceuticals, as well as began her foundational training in IP at Choate, Hall & Stewart and Vertex in various legal roles.

Ms. Shair received a bachelor’s degree with honors in chemistry from Bryn Mawr College, Bryn Mawr, Pennsylvania, a Ph.D. in chemistry from Yale University, New Haven, Connecticut and a J.D. from Boston College Law School, Newton, Massachusetts.

Ms. Shair is a member of the Massachusetts Bar and a registered patent attorney with the United States Patent and Trademark Office.

 LATEST MOVES FROM Massachusetts 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy